Hysingla ER 40 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FHY3H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,362
Award facts
- Contract value 100% obligated
- $1,362.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hysingla ER 40 mg tablets (60-count units) with a ceiling value of $1,362.27. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a competitively awarded non-set-aside contract. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. As the prime contractor on the SPE2DX IDC, the company supplies a comprehensive range of medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers worldwide. The Hysingla ER delivery order exemplifies the company's role in fulfilling specialized pharmaceutical needs within the broader DLA Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FHY3H?
SPE2DR26FHY3H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FHY3H worth?
The government has obligated $1,362 on SPE2DR26FHY3H.
Is contract SPE2DR26FHY3H an order under another contract?
Yes. SPE2DR26FHY3H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY3H competed?
The extent of competition for SPE2DR26FHY3H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award